These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7503657)

  • 1. Production, analysis, and characterization of reference materials for prostate-specific antigen.
    Garg UC; Howanitz JH; Nakamura RM; Plous RH; Eckfeldt JH
    Arch Pathol Lab Med; 1995 Dec; 119(12):1104-8. PubMed ID: 7503657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Issues on standardization of immunoassays for prostate-specific antigen: a review.
    Graves HC
    Clin Invest Med; 1993 Dec; 16(6):415-24. PubMed ID: 7516830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A complex between prostate-specific antigen and alpha 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer.
    Stenman UH; Leinonen J; Alfthan H; Rannikko S; Tuhkanen K; Alfthan O
    Cancer Res; 1991 Jan; 51(1):222-6. PubMed ID: 1703033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physiological variation of serum prostate specific antigen in the 4.0 to 10.0 ng./ml. range in male volunteers.
    Prestigiacomo AF; Stamey TA
    J Urol; 1996 Jun; 155(6):1977-80. PubMed ID: 8618301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Redesigned proficiency testing materials improve survey outcomes for prostate-specific antigen. A College of American Pathologists Ligand Assay Survey tool.
    Sokoll LJ; Witte DL; Klee GG; Chan DW
    Arch Pathol Lab Med; 2000 Nov; 124(11):1608-13. PubMed ID: 11079010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Supersensitive PSA-analysis after radical prostatectomy: a powerful tool to reduce the time gap between surgery and evidence of biochemical failure.
    Haese A; Huland E; Graefen M; Huland H
    Anticancer Res; 1999; 19(4A):2641-4. PubMed ID: 10470210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Addition of purified prostate specific antigen to serum from female subjects: studies on the relative inhibition by alpha 2-macroglobulin and alpha 1-antichymotrypsin.
    Chen Z; Komatsu K; Prestigiacomo A; Stamey TA
    J Urol; 1996 Oct; 156(4):1357-63. PubMed ID: 8808871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The importance of human glandular kallikrein and its correlation with different prostate specific antigen serum forms in the detection of prostate carcinoma.
    Recker F; Kwiatkowski MK; Piironen T; Pettersson K; Lümmen G; Wernli M; Wiefelspütz J; Graber SF; Goepel M; Huber A; Tscholl R
    Cancer; 1998 Dec; 83(12):2540-7. PubMed ID: 9874461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of the "reflex range" and appropriate cutpoints for percent free prostate-specific antigen in 413 men referred for prostatic evaluation using the AxSYM system.
    Vashi AR; Wojno KJ; Henricks W; England BA; Vessella RL; Lange PH; Wright GL; Schellhammer PF; Weigand RA; Olson RM; Dowell BL; Borden KK; Oesterling JE
    Urology; 1997 Jan; 49(1):19-27. PubMed ID: 9000179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation and characterization of free form prostate specific antigen (f-PSA) in sera of men with prostate cancer.
    Noldus J; Chen Z; Stamey TA
    J Urol; 1997 Oct; 158(4):1606-9. PubMed ID: 9302183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of the use of a commercially available kit for the identification of prostate specific antigen (PSA) in semen stains.
    Simich JP; Morris SL; Klick RL; Rittenhouse-Diakun K
    J Forensic Sci; 1999 Nov; 44(6):1229-31. PubMed ID: 10582360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ratio of alpha 1-antichymotrypsin--prostate specific antigen to total prostate specific antigen in prostate cancer diagnosis.
    Lein M; Jung K; Elgeti U; Brux B; Sinha P; Schnorr D; Loening SA
    Anticancer Res; 2000; 20(6D):4997-5001. PubMed ID: 11326657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Standardization of assay methods reduces variability of total PSA measurements: an Irish study.
    Forde JC; Marignol L; Blake O; McDermott T; Grainger R; Crowley VE; Lynch TH
    BJU Int; 2012 Sep; 110(5):644-50. PubMed ID: 22897326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An analytical comparison of the three most commonly used prostate-specific antigen assays: Tandem-R, Tandem-E, and IMx.
    Oesterling JE; Moyad MA; Wright GL; Beck GR
    Urology; 1995 Oct; 46(4):524-32. PubMed ID: 7571222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparability of serum prostate-specific antigen measurement between the Roche Diagnostics Elecsys 2010 and the Abbott Architect i2000.
    Gray MA; Cooke RR; Weinstein P; Nacey JN
    Ann Clin Biochem; 2004 May; 41(Pt 3):207-12. PubMed ID: 15117434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular forms of prostate-specific antigen and human kallikrein 2 as promising tools for early diagnosis of prostate cancer.
    Stephan C; Jung K; Lein M; Sinha P; Schnorr D; Loening SA
    Cancer Epidemiol Biomarkers Prev; 2000 Nov; 9(11):1133-47. PubMed ID: 11097220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular forms of prostate-specific antigen and human kallikrein 2 (hK2) in urine are not clinically useful for early detection and staging of prostate cancer.
    Pannek J; Rittenhouse HG; Evans CL; Finlay JA; Bruzek DJ; Cox JL; Chan DW; Subong EN; Partin AW
    Urology; 1997 Nov; 50(5):715-21. PubMed ID: 9372881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective study to evaluate the role of complexed prostate specific antigen and free/total prostate specific antigen ratio for the diagnosis of prostate cancer.
    Mitchell ID; Croal BL; Dickie A; Cohen NP; Ross I
    J Urol; 2001 May; 165(5):1549-53. PubMed ID: 11342915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Technicon Immuno 1 PSA assay measures both free and alpha-1-antichymotrypsin-complexed prostate-specific antigen on an equimolar basis.
    Zhou Z; Ng PC; Very DL; Allard WJ; Yeung KK
    J Clin Lab Anal; 1996; 10(3):155-9. PubMed ID: 8731504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual monoclonal antibody immunoassay for free prostate-specific antigen.
    Wang TJ; Hill TM; Sokoloff RL; Frankenne F; Rittenhouse HG; Wolfert RL
    Prostate; 1996 Jan; 28(1):10-6. PubMed ID: 8545276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.